A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test
A Registry to Collect Characteristics and Outcomes From Patients With Solid Tumors Profiled With a Next-Generation Sequencing Test (WAYFIND-R)
1 other identifier
observational
7,864
30 countries
131
Brief Summary
WAYFIND-R is a registry that aims to capture high-quality real-world data linking next-generation sequencing, treatments and outcomes from cancer patients diagnosed with a solid tumour. The WAYFIND-R has three main overarching objectives: 1. To provide a platform to support the design and conduct of clinical and epidemiological research; 2. To develop an evidence-generation platform to better understand health outcomes and cancer care processes; and 3. To characterize the treatments and clinical course of solid tumor cancers in patients who have undergone NGS testing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2020
Longer than P75 for all trials
131 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2020
CompletedFirst Posted
Study publicly available on registry
August 27, 2020
CompletedStudy Start
First participant enrolled
August 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 24, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 24, 2026
CompletedMay 27, 2026
May 1, 2026
5.7 years
August 25, 2020
May 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Overall Survival
From date of registry entry until death, for up to 5 years
Eligibility Criteria
Male and Female adult participants who are diagnosed with solid tumour cancers (at any anatomical location) and at any stage of the disease who have undergone an NGS test.
You may qualify if:
- Participant is an adult (according to the age of majority as defined by local regulations)
- Participant is currently diagnosed with any type of solid tumour cancer, at any stage of the disease, at the enrollment date (informed consent date)
- Participant has undergone NGS testing, no longer than 3 months prior to the enrollment date, irrespective of the availability of test results
- Informed consent has been obtained from the participant or legally authorized representative, as per local regulations
You may not qualify if:
- Participant has a prior or current diagnosis of haematological malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (136)
Instituto Alexander Fleming
Buenos Aires, 1426, Argentina
CEMIC
Buenos Aires, C1431FWN, Argentina
Lkh-Univ. Klinikum Graz
Graz, 8036, Austria
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, 90035-001, Brazil
Instituto do Cancer do Estado de Sao Paulo - ICESP
São Paulo, São Paulo, 01246-000, Brazil
Hospital Alemao Oswaldo Cruz
São Paulo, São Paulo, 01323-903, Brazil
D'or Instituto de Pesquisa e Educação
Rio de Janeiro, Brazil
Beneficencia Portuguesa de Sao Paulo
São Paulo, 01321-00, Brazil
Alberta Health Services
Calgary, Alberta, T2N 4N2, Canada
The Ottawa Hospital - General Campus
Ottawa, Ontario, K1H 8L6, Canada
Medicina de Precisión - Celerity
Las Condes, 7560908, Chile
Centro de Cancer Pontificie Universidad Catolica de Chile
Santiago, 8330074, Chile
Fundación CTIC - Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo
Bogota, D.C., 110131, Colombia
Fundacion Cardioinfantil
Bogotá, Colombia
Organizacion Sanitas Internacional
Bogotá, Colombia
Fundacion Clinica Valle del Lili
Cali, Colombia
Instituto Cancerología Medellin
Medellín, 050024, Colombia
Clinica ASTORGA
Medellín, 50010, Colombia
International Medical Center
Cairo, Egypt
East Tallinn Central Hospital
Tallinn, 11312, Estonia
North Estonia Medical Centre Foundation
Tallinn, 13419, Estonia
Tartu Uni Hospital
Tartu, 51014, Estonia
Chu Amiens - Picardie
Amiens, 80054, France
Hopital Jean Minjoz
Besançon, 25030, France
Centre Hospitalier de Béthune-Beuvry
Béthune, 62408, France
Chu Brest - Hôpital Morvan
Brest, 29200, France
Centre Francois Baclesse
Caen, 14076, France
Centre Hospitalier de Chauny
Chauny, 02300, France
Centre Jean Perrin
Clermont-Ferrand, 63011, France
Groupe Hospitalier Public Du Sud De L'Oise GHPSO
Creil, 60109, France
Centre hospitalier universitaire Dijon-Bourgogne
Dijon, 21079, France
Hôpital Franco-Britannique- Fondation Cognacq-Jay
Levallois-Perret, 92300, France
Centre Oscar Lambret
Lille, 59020, France
Centre Leon Berard
Lyon, 69373, France
APHM
Marseille, 13385, France
Hopital de La Timone - CHU de Marseille
Marseille, 13385, France
Institut Régional du Cancer de Montpellier
Montpellier, 34298, France
Institut Curie
Paris, 75005, France
CH de Cornouailles
Quimper, 29107, France
Centre Eugene Marquis
Rennes, 35000, France
CHU Saint Etienne - Hôpital Nord
Saint-Etienne, 42055, France
Hôpital Privé de la Loire, Ramsay Saint Etienne
Saint-Etienne, 42100, France
CHI de Toulon - Hôpital Sainte Musse
Toulon, 83056, France
Gustave Roussy
Villejuif, 94800, France
HELIOS Klinikum Bad Saarow
Bad Saarow, 15526, Germany
DRK Kliniken Berlin
Berlin, 12559, Germany
Universitätsklinikum Halle (Saale)
Halle, 06120, Germany
Asklepios Klinik Altona
Hamburg, 22763, Germany
Medizinische Hochschule Hannover
Hanover, 30625, Germany
SLK-Kliniken Heilbronn GmbH;Klinik für Innere Medizin III
Heilbronn, 74078, Germany
Praxis für Hämatologie, Onkologie und Palliativmedizin
Mönchengladbach, 41066, Germany
Klinikum am Steinenberg / Ermstalklinik
Reutlingen, 72764, Germany
Katharinenhospital Stuttgart
Stuttgart, 70174, Germany
Marien-Hospital Wesel
Wesel, 46483, Germany
General Hospital "G.Papanikolaou"
Asvestochóri, 570 10, Greece
Henri Dunant Hospital
Athens, 115 26, Greece
Alexandras General Hospital of Athens
Athens, 115 28, Greece
Metropolitan Hospital Fourth Oncology Clinic
Faliro, 185 47, Greece
Bioclinic Thessaloniki
Thessaloniki, 546 22, Greece
Orszagos Onkologiai Intezet
Budapest, 1122, Hungary
Bács-Kiskun Vármegyei Oktatókórház
Kecskemét, 6000, Hungary
Pécsi Tudományegyetem
Pécs, 7623, Hungary
Manipal Hospital
Bangalore, Karnataka, 560017, India
HealthCare Global Enterprises Limited
Banglore, Karnataka, 560027, India
Tata Memorial Hospital
Mumbai, Maharashtra, 400012, India
MOC Cancer Care & Research Centre (Unit of Cellcure Cancer Centre Pvt Ltd)
Mumbai, Maharashtra, 400036, India
Bhaktivedanta Hospital and research institute
Thane, Maharashtra, 401107, India
Max Super Speciality Hospital
New Delhi, National Capital Territory of Delhi, 110017, India
Apollo Hospitals
Chennai, Tamil Nadu, 600035, India
Indo-American Cancer Hospital & Research Center
Hyderabad, Telangana, 500034, India
Mid-Land Regional Hospital Tullamore
CO Offaly, R35 NY51, Ireland
Adelaide & Meath Hospital, Dublin, Incorporating the National Children's Hospital
Dublin, 24, Ireland
St Vincent'S Uni Hospital
Dublin, 4, Ireland
St James's Hospital
Dublin, 8, Ireland
Beacon Hospital
Dublin, D18 AK68, Ireland
Hadassah University Hospital - Ein Kerem
Jerusalem, 9112001, Israel
Sourasky / Ichilov Hospital
Tel Aviv, 6423906, Israel
American University of Beirut - Medical Center
Beirut, 1107 2020, Lebanon
Hotel Dieu de France
Beirut, 2063 1111, Lebanon
Hammoud Hospital
Saida, 6520, Lebanon
ONCARE Viaducto Napoles
Mexico City, Mexico CITY (federal District), 03810, Mexico
Clínica Integral Internacional de Oncología S de RL de CV
Puebla City, Mexico CITY (federal District), Mexico
The American British Cowdray Hospital/ Hospital Abc
Mexico City, 01120, Mexico
Cebu Doctors' University Hospital
Cebu City, 6000, Philippines
Metro Davao Medical and Research Center
Davao City, 8000, Philippines
St Lukes Medical Center
Quezon City, 1102, Philippines
Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie
Warsaw, 02-781, Poland
Hospital CUF Porto
Porto, 4100-180, Portugal
IPO do Porto
Porto, 4200-072, Portugal
National Guard King Abdulaziz Medical City
Riyadh, 11426, Saudi Arabia
University Hospital Medical Center Bezanijska kosa
Belgrade, 11080, Serbia
Oncomed-System
Belgrade, Serbia
SIRIUS Medical
Belgrade, Serbia
Special hospital for internal diseases Vesalius
Belgrade, Serbia
Oncology Institute of Vojvodina
Kamenitz, 21204, Serbia
Narodny Onkologicky Ustav
Bratislava, 833 10, Slovakia
University Clinic Golnik
Golnik, 4204, Slovenia
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
IATROS International
Bloemfontein, 9301, South Africa
Linksfield Oncology Inc.
Johannesburg, 2192, South Africa
Medical Oncology Centre of Rosebank
Johannesburg, 2196, South Africa
Wilgers Oncology Centre
Pretoria, 0001, South Africa
Hospital Universitario Son Espases
Palma de Mallorca, Balearic Islands, 07014, Spain
Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico
Jaén, 23007, Spain
Hospital Clinico Universitario Virgen de la Victoria;Servicio de Oncologia
Málaga, 29011, Spain
Hospital Universitario Miguel Servet
Zaragoza, 50009, Spain
Chang Gung Medical Foundation - Kaohsiung
Kaohisung, 833, Taiwan
Taipei Veterans General Hospital
Taipei, 112, Taiwan
Chung Gung Memorial Hospital
Taoyuan County, 333, Taiwan
Chulalongkorn Hospital
Bangkok, 10330, Thailand
Faculty of Med. Siriraj Hosp.
Bangkok, 10700, Thailand
Medicana International Zincirlikuyu Hospital
Istanbul, Enter Text, 34394, Turkey (Türkiye)
Memorial Ankara Hastanesi
Ankara, 06520, Turkey (Türkiye)
Trakya University Medical Faculty
Edirne, 22030, Turkey (Türkiye)
Ba?c?lar Medipol Mega Üniversite Hastanesi
Istanbul, 34214, Turkey (Türkiye)
Medicana International Atasehir Hospital
Istanbul, 34750, Turkey (Türkiye)
Medicana International Izmir Hospital
Izmir, 35170, Turkey (Türkiye)
Ac?badem Maslak Hastanesi Büyükdere
Sar?yer/?stanbul, 34457, Turkey (Türkiye)
Ac?badem Adana Hospital, Oncology Department
Seyhan/Adana, 01130, Turkey (Türkiye)
Tawam Hospital
Al Ain City, 15258, United Arab Emirates
Mediclinic City Hospital
Dubai, United Arab Emirates
Blackpool Victoria Hospital
Blackpool, FY3 8NR, United Kingdom
Bristol Haematology and Oncology centre
Bristol, BS2 8ED, United Kingdom
Royal Sussex County Hospital
Eastbourne, BN2 1ES, United Kingdom
Royal Devon & Exeter Hospital
Exeter, EX2 5DW, United Kingdom
Gloucestershire Royal Hospital
Gloucester, GL1 3NN, United Kingdom
Royal Surrey County Hospital
Guildford, GU2 7XX, United Kingdom
St Georges University Hospitals NHS Foundation Trust
London, SW17 0RE, United Kingdom
Freeman Hospital
New Castle Upon Tyne, NE7 7DN, United Kingdom
Mount Vernon Hospital
Northwood, HA6 2RN, United Kingdom
Musgrove Park Hospital
Somerset, TA1 5DA, United Kingdom
Kings Mill Hospital
Sutton in Ashfield, NG17 4JL, United Kingdom
Torbay Hospital
Torquay, TQ2 7AA, United Kingdom
Hanoi Oncology Hospital
Hanoi, 100000, Vietnam
K hospital
Hanoi, 100000, Vietnam
Ho Chi Minh City Oncology Hospital
Ho Chi Minh City, Vietnam
Related Publications (1)
Dienstmann R, Hackshaw A, Blay JY, Le Tourneau C. Core variables for real-world clinicogenomic data collection in precision oncology. ESMO Real World Data Digit Oncol. 2025 Feb 27;7:100117. doi: 10.1016/j.esmorw.2025.100117. eCollection 2025 Mar.
PMID: 41647341DERIVED
Related Links
Study Officials
- STUDY DIRECTOR
Clinical Trials
Hoffmann-La Roche
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2020
First Posted
August 27, 2020
Study Start
August 27, 2020
Primary Completion
April 24, 2026
Study Completion
April 24, 2026
Last Updated
May 27, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
For eligible studies, qualified researchers may request access to individual patient level clinical data. See Roche's commitment to transparency of clinical study information here: https://go.roche.com/data\_sharing